PARK7 and carcinoma of supraglottis: DJ-1, also known as Parkinson’s disease protein 7 (PARK7), is an emerging oncogenic biomarker with high expression levels reported in various types of cancer, including breast, pancreatic, and supraglottic cancers [124,125,126].